Thyrocare Technologies Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review
- June 15, 2026
- Posted by: Kunal Singla
- Category: News
Thyrocare Technologies CMP: Rs 533.75 (2026). 52W High: Rs 578. 52W Low: Rs 317. Mkt Cap: Rs 8,477 Cr. P/E: 57.7. Analyst Consensus: Rs 600.
The Thyrocare Technologies stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any Thyrocare Technologies share price prediction as one data point and not as a guarantee of future performance.
This article reviews every dimension of the Thyrocare Technologies stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.
Click Here – Get Free Investment Predictions
What Analysts Predict for Thyrocare Technologies Stock in 2026
Analyst consensus on the Thyrocare Technologies stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and Kotak Securities. All figures are sourced from publicly available research and should be verified before publishing.
| Brokerage | Rating | Thyrocare Technologies Stock Prediction (Rs) | Updated |
|---|---|---|---|
| JM Financial | Neutral | Rs 620 | 2026 |
| Kotak Securities | Neutral | Rs 580 | 2026 |
| Analyst Consensus | — | Rs 600 | 2026 |
The Thyrocare Technologies stock prediction range reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the Thyrocare Technologies stock forecast from the current price of Rs 533.75 may or may not be realised by end of 2026.
3 Stocks Building Serious Momentum Right Now
When Univest analysts identify high-conviction stock opportunities, investors pay attention.
Our research team has shortlisted the Top Stocks to Buy based on current market momentum, sector trends & growth potential for 2026.
- Discover stocks investors are actively accumulating
- High-conviction opportunities backed by research
- Designed for the next phase of market growth
Unlock the latest Top Stock Picks now on Univest
Thyrocare Technologies Company Overview
Thyrocare Technologies is a leading healthcare services provider operating hospitals, diagnostics or specialty facilities across India. The Thyrocare Technologies stock prediction for 2026 reflects structural growth in healthcare demand and operating leverage from bed expansion.
| Metric | Value |
|---|---|
| NSE Ticker | THYROCARE |
| Sector | Healthcare Services and Hospitals |
| CMP | Rs 533.75 (2026) |
| 52 Week High | Rs 578 |
| 52 Week Low | Rs 317 |
| Market Cap | Rs 8,477 Cr |
| P/E Ratio | 57.7 |
| Thyrocare Technologies Stock Prediction Consensus (12M) | Rs 600 |
Thyrocare Technologies Stock Prediction by Time Horizon
Analysts split the Thyrocare Technologies share price prediction across time frames as near-term drivers differ materially from the long-term view.
Short-Term Thyrocare Technologies Stock Prediction
The near-term Thyrocare Technologies stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 533.75 are being watched closely. A short-term Thyrocare Technologies share price prediction carries the most uncertainty of any time horizon.
12-Month Thyrocare Technologies Stock Prediction
JM Financial targets Rs 620 (Neutral) and Kotak Securities targets Rs 580 (Neutral). Most desks refresh their Thyrocare Technologies stock forecast within two to four weeks of each quarterly earnings print. The Thyrocare Technologies share price prediction should be verified against the most recent analyst reports.
Long-Term Thyrocare Technologies Stock Prediction
The long-term Thyrocare Technologies stock prediction is built on assumptions about demand recovery, margin expansion and revenue diversification in the Healthcare Services and Hospitals sector. The long-term Thyrocare Technologies share price prediction carries the most uncertainty and should be treated as directional guidance only.
Thyrocare Technologies Stock Forecast: Key Factors
The following four factors appear consistently in research reports on the Thyrocare Technologies stock prediction and are the primary inputs into the bull and bear case scenarios.
Bed Addition and Occupancy
Hospital bed additions and occupancy rates are the primary metrics in the Thyrocare Technologies stock forecast. Analysts look for occupancy above 65 percent as the basis for a higher Thyrocare Technologies share price prediction.
Revenue per Occupied Bed
Revenue per occupied bed improvement reflects the shift to higher-margin specialties. Analysts revise the Thyrocare Technologies share price prediction upward when per-bed revenue grows consistently.
EBITDA Margin Maturity
A portfolio shift toward mature hospitals supports the bullish Thyrocare Technologies stock prediction, while new hospital ramp-ups dilute margins in the near term.
International Patient Revenue
Medical tourism revenue provides premium pricing and diversifies the revenue base, supporting the Thyrocare Technologies stock forecast and premium valuation.
Thyrocare Technologies Stock Prediction: Bull and Bear Scenarios
| Scenario | Thyrocare Technologies Stock Prediction | Key Conditions |
|---|---|---|
| Bull Case | Rs 620 | Strong execution, margin improvement, favourable macro and sector re-rating |
| Base Case | Rs 600 | Steady performance, gradual recovery, margins hold, growth on track |
| Bear Case | Rs 317 | Demand deterioration, margin pressure, sector de-rating and macro headwinds |
The bull case Thyrocare Technologies stock forecast of Rs 620 assumes most positive variables converge. The base case of Rs 600 is the analyst consensus and may or may not be achieved.
How Analysts Are Reading the Thyrocare Technologies Stock Story
Analyst reviews of the Thyrocare Technologies share price prediction highlight the company’s core strengths in Healthcare Services and Hospitals alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the Thyrocare Technologies stock prediction consensus is built on real business strengths set against real risks.
Key Risks to the Thyrocare Technologies Stock Prediction
New Hospital Ramp-Up Costs
New hospital investments have multi-year ramp-up periods during which margins are diluted. This is a recurring near-term risk to the Thyrocare Technologies stock prediction.
Regulatory and Price Cap Risk
Government-mandated price caps on medical procedures affect hospital revenues and can compress the Thyrocare Technologies stock forecast.
Competition
New hospital chains expanding into metro and tier 2 cities create competitive pressure on occupancy and billing, which is a recurring caution in the Thyrocare Technologies share price prediction.
Medical Cost Inflation
Rising manpower and consumables costs affect EBITDA margins and the Thyrocare Technologies stock forecast. Cost risk is reflected in the width of the Thyrocare Technologies share price prediction range.
How to Monitor the Thyrocare Technologies Stock Forecast
Track the Thyrocare Technologies share price prediction consensus quarterly. After every earnings release, most brokerages revise their Thyrocare Technologies stock forecast within two weeks. Comparing the revised Thyrocare Technologies stock prediction to the previous estimate tells you whether analyst sentiment is improving or deteriorating.
Compare the current price of Rs 533.75 with the analyst target range of Rs 620 to Rs 580. A wide Thyrocare Technologies stock prediction band reflects genuine uncertainty, so position size should reflect that range rather than the midpoint alone.
Review the Thyrocare Technologies share price prediction every quarter against key business metrics for the Healthcare Services and Hospitals sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.
Check Live Thyrocare Technologies Fundamentals on the Univest Screener
Conclusion
The Thyrocare Technologies stock prediction for 2026 reflects the analyst community’s assessment of Thyrocare Technologies’s competitive position, earnings trajectory and macro environment. JM Financial holds a Neutral stance with a target of Rs 620 while Kotak Securities has a Neutral rating with a target of Rs 580, giving an analyst consensus of Rs 600.
The Thyrocare Technologies stock forecast is set against near-term risks that make the Thyrocare Technologies share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking changes in the Thyrocare Technologies stock prediction over time is more valuable than relying on any single estimate.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Download the Univest iOS App or Univest Android App to track the live Thyrocare Technologies stock prediction and share price prediction changes in real time.
Disclaimer: Data and figures in this article are sourced from publicly available information and may or may not be accurate. Analyst price targets are from public brokerage reports and should be independently verified. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Thyrocare Technologies Stock Prediction 2026
What is the Thyrocare Technologies stock prediction for 2026?
Ans. The Thyrocare Technologies stock prediction for 2026 is based on analyst consensus from JM Financial and Kotak Securities. The consensus target is Rs 600. All estimates may or may not be achieved.
Is the Thyrocare Technologies stock prediction bullish or bearish?
Ans. JM Financial has a Neutral rating with target Rs 620. Kotak Securities has a Neutral rating with target Rs 580. The Thyrocare Technologies stock forecast reflects genuine analyst diversity of opinion.
What is the Thyrocare Technologies share price prediction based on fundamentals?
Ans. The Thyrocare Technologies share price prediction rests on the bed addition pipeline, occupancy trend, revenue per bed and EBITDA margin maturity. Analysts tracking Thyrocare Technologies closely cite these as the primary drivers of the 2026 outlook.
What is the long-term Thyrocare Technologies stock prediction?
Ans. The long-term Thyrocare Technologies stock prediction assumes the company sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 600 is the nearest reliable anchor point.
What are the key risks to the Thyrocare Technologies stock prediction?
Ans. The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every Thyrocare Technologies stock prediction should be read alongside its risk assumptions.
What does the Thyrocare Technologies stock forecast say for 2026?
Ans. JM Financial: Neutral target Rs 620. Kotak Securities: Neutral target Rs 580. These Thyrocare Technologies share price prediction estimates may or may not prove accurate.
Where can I track the latest Thyrocare Technologies stock prediction?
Ans. Track the latest Thyrocare Technologies stock prediction on the NSE and BSE websites and on the Univest app and screener for live price and updated analyst targets.
